VE
Veeva Systems
VEEV·NYSEPleasanton CAFounded 20077,000 employees
Large CapbiotechPublicOncology
Platform: Pharma Cloud CRM
Market Cap
$35B
All Drugs
8
Clinical Trials
11
Failed / Terminated
1
FDA Approved
0
Stock Price & Catalysts (VEEV)
Loading VEEV stock data...
Drug Pipeline (8 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Semazasiran | VEE-1346 | NDA/BLA | 1 | IL-23 | MesoAML | ||
| Bemaratamab | VEE-9659 | Phase 2/3 | 1 | CFTR | Urothelial CaEpilepsy | ||
| VEE-9538 | VEE-9538 | Phase 1 | 1 | HER2 | Prostate CaCeliac | ||
| VEE-3535 | VEE-3535 | NDA/BLA | 1 | TIM-3 | Cervical CaMCC | ||
| VEE-8520 | VEE-8520 | NDA/BLA | 2 | ALK | NASHFabry | ||
| VEE-457 | VEE-457 | Phase 1 | 2 | BCL-2 | CFADHD | ||
| VEE-7651 | VEE-7651 | Preclinical | 2 | CDK4/6 | MDDObesity | ||
| Tixasacituzumab | VEE-1815 | Phase 1 | 1 | PRMT5 | Gastric CaUrothelial Ca |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (11)